DBI-001

· DermBiont, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DBI-001, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis [Phase 2]